Literature DB >> 1352209

Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers.

G D Byrd1, K M Chang, J M Greene, J D deBethizy.   

Abstract

Urinary nicotine metabolic output was profiled for 11 smokers who smoked their regular cigarette brands ad libitum. Thermospray liquid chromatography/mass spectrometry was used to monitor nicotine and eight metabolites, including glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine that were determined indirectly using enzyme hydrolysis. These results were used to estimate an average, steady-state concentration in a 24-hr urine sample during ad libitum smoking and to assess interindividual variability in the excretion of these metabolites. The variability in absolute amount among the nine analytes ranged from 35 to 70% for these smokers. The glucuronide conjugates constituted an average of 29% of all urinary metabolites monitored in this study. trans-3'-Hydroxycotinine in the free form constitutes the largest single metabolite in smokers' urine, with an average of 35% of the total. The sums of nicotine metabolites determined here are very close to the Federal Trade Commission yields of nicotine for the total number of cigarettes smoked by these subjects during the urine collection interval. These results indicate that a large proportion of the nicotine absorbed while smoking can be accounted for as urinary metabolites of nicotine, including glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352209

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  28 in total

1.  A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine.

Authors:  Taraneh Taghavi; Maria Novalen; Caryn Lerman; Tony P George; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-31       Impact factor: 4.254

2.  In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposure.

Authors:  Lucy A Clunes; Arlene Bridges; Neil Alexis; Robert Tarran
Journal:  J Anal Toxicol       Date:  2008-04       Impact factor: 3.367

3.  A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers.

Authors:  Mengyao Jin; Ravinder Earla; Ankit Shah; Rajya L Earla; Raeesa Gupte; Ashim K Mitra; Anil Kumar; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-08       Impact factor: 4.147

4.  UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.

Authors:  Catherine A Wassenaar; David V Conti; Soma Das; Peixian Chen; Edwin H Cook; Mark J Ratain; Neal L Benowitz; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

5.  Metabolomics evaluation of the impact of smokeless tobacco exposure on the oral bacterium Capnocytophaga sputigena.

Authors:  Jinchun Sun; Jinshan Jin; Richard D Beger; Carl E Cerniglia; Maocheng Yang; Huizhong Chen
Journal:  Toxicol In Vitro       Date:  2016-07-30       Impact factor: 3.500

6.  Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking.

Authors:  N L Benowitz; P Jacob
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 7.  Aspects of the oxidative metabolism of nicotine.

Authors:  G B Neurath
Journal:  Clin Investig       Date:  1994-02

8.  Comparison of measured and FTC-predicted nicotine uptake in smokers.

Authors:  G D Byrd; J H Robinson; W S Caldwell; J D deBethizy
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 9.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.

Authors:  A Joseph Bloom; Sharon E Murphy; Maribel Martinez; Linda B von Weymarn; Laura J Bierut; Alison Goate
Journal:  Pharmacogenet Genomics       Date:  2013-02       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.